Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kori Ann Johnston

Nurse Practitioner, Acute Care Los Angeles, CA Nurse Practitioner

NPI 1275141657 CMS profile 11138798

1520 San Pablo St Ste 4300, Los Angeles, CA 90033

Open in the dashboard

General payments

$41,829

197 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kori Ann Johnston of Los Angeles, CA is reported in the CMS Open Payments database as having received $41,829 across 197 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $292 3
2024 General $17,448 55
2023 General $15,142 75
2022 General $8,765 60
2021 General $181 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kori Ann Johnston
  • Nurse Practitioner, Acute Care median
  • Middle half of Nurse Practitioner, Acute Care
  • National median

In program year 2025, general payments to Kori Ann Johnston were reported at $292. Among 11,827 Nurse Practitioner, Acute Care profiles paid that year, the median was $152 and the middle half received between $48 and $458.

Show as a table
Year Kori Ann Johnston Nurse Practitioner, Acute Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $181 $123 $38–$327 $132
2022 $8,765 $130 $44–$369 $149
2023 $15,142 $144 $49–$410 $160
2024 $17,448 $146 $48–$433 $164
2025 $292 $152 $48–$458 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $27,203 148 payments
  2. Abiomed $13,573 38 payments
  3. Edwards Lifesciences Corporation $459 2 payments
  4. Medtronic, Inc. $181 4 payments
  5. Atricure, Inc. $139 1 payment
  6. Baxter Healthcare $103 1 payment
  7. Bolton Medical Inc $100 1 payment
  8. Takeda Pharmaceuticals U.S.A., Inc. $36 1 payment
  9. Scpharmaceuticals Inc. $35 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $11,309 37 payments
  2. Consulting Fee $10,944 11 payments
  3. Food and Beverage $10,076 144 payments
  4. Honoraria $9,500 5 payments
Products named General payments · program years 2021–2025
  1. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Heart failure $23,854 125 payments
  2. Impella $13,444 37 payments
  3. CARDIOMEMS $1,697 8 payments
  4. 2ND GEN CENTRIMAG PRIMARY CONSOLE $823 10 payments
  5. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Neuromodulation $785 3 payments
  6. MITRIS RESILIA Mitral Valve $257 1 payment
  7. SAPIEN 3 Ultra RESILIA $202 1 payment
  8. HeartWare HVAD $181 4 payments
  9. SYNERGY ABLATION SYSTEM $139 1 payment
  10. COSEAL $103 1 payment
  11. Other $195 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

197 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record